Senseonics Holdings, Inc. (SENS) shareholders
Close on Nov 17, 2026Market cap $537.20MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Robert J. Smith Joint filing with Energy Capital, LLC (6.10%) | 50,035,000 | 6.14% | 13G (passive) amendment | May 19, 2025 |
| John Petry Joint filing with Sessa Capital IM, L.P. (9.90%) | 12,437,532 | 9.90% | 13G (passive) | Jun 30, 2026 |
| BlackRock, Inc. | 2,743,263 | 5.20% | 13G (passive) amendment | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SENS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 4,437,532 | 8.39% | $25.21M | +2,671,439 | 0.42% |
| BlackRock, Inc. | 2,793,558 | 5.28% | $15.87M | +2,224,829 | 0.00% |
| Vanguard Capital Management LLC | 1,779,398 | 3.37% | $10.11M | +162,201 | 0.00% |
| Avidity Partners Management LP | 1,600,000 | 3.03% | $9.09M | New | 1.46% |
| Sio Capital Management, LLC | 1,592,692 | 3.01% | $9.05M | +1,476,908 | 1.50% |
| UBS Group AG | 1,487,429 | 2.81% | $8.45M | +1,039,200 | 0.00% |
| Geode Capital Management, LLC | 1,132,210 | 2.14% | $6.43M | +665,695 | 0.00% |
| Masters Capital Management LLC | 700,000 | 1.32% | $3.98M | +200,000 | 0.10% |
| State Street Corp | 511,117 | 0.97% | $2.90M | +330,836 | 0.00% |
| Marshall Wace, Llp | 405,695 | 0.77% | $2.30M | −58,680 | 0.00% |
| Bank Of America Corp /De/ | 394,465 | 0.75% | $2.24M | +337,501 | 0.00% |
| Charles Schwab Investment Management Inc | 393,211 | 0.74% | $2.23M | +172,034 | 0.00% |
| Northern Trust Corp | 332,266 | 0.63% | $1.89M | +249,989 | 0.00% |
| Vanguard Fiduciary Trust Co | 331,353 | 0.63% | $1.88M | +106,186 | 0.00% |
| Walleye Capital LLC | 324,264 | 0.61% | $1.84M | New | 0.01% |
| Vanguard Portfolio Management LLC | 272,375 | 0.52% | $1.55M | New | 0.00% |
| Goldman Sachs Group Inc | 231,509 | 0.44% | $1.31M | +85,227 | 0.00% |
| Morgan Stanley | 164,984 | 0.31% | $937.11K | +41,041 | 0.00% |
| Russell Investments Group, Ltd. | 153,216 | 0.29% | $870.27K | +153,209 | 0.00% |
| Trexquant Investment LP | 135,128 | 0.26% | $767.53K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 108 | 21M | 39.4% | 42 / 32 | 15 / 17 | 13M | 1M |
| Q1 2026 | 85 | 9M | 16.6% | 25 / 17 | 19 / 22 | 5M | 1M |
| Q4 2025 | 85 | 7M | 12.5% | 83 / 0 | 1 / 5 | 6M | 0M |
| Q3 2025 | 8 | 0M | 0.8% | 8 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
67 funds held SENS in Q2 2026, 79% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SENS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,175,190 | 2.22% | $6.68M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 972,810 | 1.84% | $5.53M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 559,672 | 1.06% | $3.18M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 430,028 | 0.81% | $2.16M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 370,510 | 0.70% | $2.10M | 0.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 184,805 | 0.35% | $1.25M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 179,484 | 0.34% | $1.22M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 132,509 | 0.25% | $752.65K | 0.05% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 96,032 | 0.18% | $483.04K | 0.01% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 74,026 | 0.14% | $502.64K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 73,750 | 0.14% | $418.90K | 0.01% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 62,100 | 0.12% | $352.73K | 0.24% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 57,316 | 0.11% | $389.18K | 0.00% | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 52,133 | 0.10% | $262.23K | 0.01% | Jul 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 51,099 | 0.10% | $290.24K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brian B. Hansen | Chief Commercial Officer, Director | 119,087 | 0.23% | Nov 17, 2026 |
| Francine Kaufman | Chief Medical Officer, Director | 166,989 | 0.32% | Nov 17, 2026 |
| Timothy T. Goodnow | President and CEO, Director | 1,082,550 | 2.05% | Nov 17, 2026 |
| Frederick T. Sullivan | Chief Financial Officer | 211,872 | 0.40% | Nov 17, 2026 |
| Kenneth L. Horton | GC & Corp. Development Advisor | 268,647 | 0.51% | Nov 17, 2026 |
| Mukul JAIN | Chief Operating Officer | 470,176 | 0.89% | Nov 17, 2026 |
| Douglas A. Roeder | Director | 189,712 | 0.36% | Nov 16, 2026 |
| Edward Fiorentino | Director | 87,392 | 0.17% | Oct 5, 2026 |
| Edelman Steven | Director | 92,375 | 0.17% | Oct 5, 2026 |
| Douglas S. Prince | Director | 70,146 | 0.13% | Oct 5, 2026 |
| Stephen P. DeFalco | Director | 111,019 | 0.21% | May 21, 2026 |
| Sharon Larkin | Director | 41,862 | 0.08% | May 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Frederick T. Sullivan Chief Financial Officer | Nov 15, 2026 | Tax withholding | −14,605 | $10.58 | $154.52K | 211,872 |
| Francine Kaufman Chief Medical Officer, Director | Nov 15, 2026 | Tax withholding | −10,068 | $10.58 | $106.52K | 166,989 |
| Mukul JAIN Chief Operating Officer | Nov 15, 2026 | Tax withholding | −30,687 | $10.58 | $324.67K | 470,176 |
| Timothy T. Goodnow President and CEO, Director | Nov 15, 2026 | Tax withholding | −61,198 | $10.58 | $647.47K | 1,082,550 |
| Kenneth L. Horton GC & Corp. Development Advisor | Nov 15, 2026 | Tax withholding | −16,865 | $10.58 | $178.43K | 268,647 |
| Brian B. Hansen Chief Commercial Officer, Director | Nov 15, 2026 | Tax withholding | −7,850 | $10.58 | $83.05K | 119,087 |
| Douglas A. Roeder Director | Nov 13, 2026 | Buy | +17,040.716 | $10.32 | $175.86K | 189,712 |
| Edelman Steven Director | Oct 1, 2026 | Award | +1,292 | $9.96 | $12.87K | 92,375 |
| Douglas S. Prince Director | Oct 1, 2026 | Award | +815 | $9.96 | $8.12K | 70,146 |
| Edward Fiorentino Director | Oct 1, 2026 | Award | +1,418 | $9.96 | $14.12K | 87,392 |
| Douglas A. Roeder Director | Oct 1, 2026 | Award | +1,480 | $9.96 | $14.74K | 172,671 |
| Douglas A. Roeder Director | Aug 19, 2026 | Buy | +13,953.28 | $8.98 | $125.30K | 171,191 |
| Douglas S. Prince Director | Jul 1, 2026 | Award | +1,515 | $5.36 | $8.12K | 69,331 |
| Douglas A. Roeder Director | Jul 1, 2026 | Award | +2,751 | $5.36 | $14.75K | 157,238 |
| Edward Fiorentino Director | Jul 1, 2026 | Award | +2,635 | $5.36 | $14.12K | 85,974 |
| Edelman Steven Director | Jul 1, 2026 | Award | +2,402 | $5.36 | $12.87K | 91,083 |
| Kenneth L. Horton GC & Corp. Development Advisor | Jun 15, 2026 | Tax withholding | −9,545 | $7.18 | $68.53K | 285,512 |
| Frederick T. Sullivan Chief Financial Officer | Jun 15, 2026 | Tax withholding | −5,397 | $7.18 | $38.75K | 226,477 |
| Brian B. Hansen Chief Commercial Officer, Director | Jun 15, 2026 | Tax withholding | −5,420 | $7.18 | $38.92K | 126,937 |
| Mukul JAIN Chief Operating Officer | Jun 15, 2026 | Tax withholding | −16,194 | $7.18 | $116.27K | 500,863 |
| Francine Kaufman Chief Medical Officer, Director | Jun 15, 2026 | Tax withholding | −4,010 | $7.18 | $28.79K | 177,057 |
| Timothy T. Goodnow President and CEO, Director | Jun 15, 2026 | Tax withholding | −32,598 | $7.18 | $234.05K | 1,143,748 |
| Douglas A. Roeder Director | May 20, 2026 | Award | +9,852 | – | – | 154,487 |
| Douglas S. Prince Director | May 20, 2026 | Award | +9,852 | – | – | 67,816 |
| Stephen P. DeFalco Director | May 20, 2026 | Award | +9,852 | – | – | 111,019 |
| Edward Fiorentino Director | May 20, 2026 | Award | +9,852 | – | – | 83,339 |
| Edelman Steven Director | May 20, 2026 | Award | +9,852 | – | – | 88,681 |
| Sharon Larkin Director | May 20, 2026 | Award | +9,852 | – | – | 41,862 |
| Brian B. Hansen Chief Commercial Officer, Director | May 19, 2026 | Award | +90,253 | – | – | 132,357 |
| Francine Kaufman Chief Medical Officer, Director | May 19, 2026 | Award | +63,177 | – | – | 181,067 |
| Mukul JAIN Chief Operating Officer | May 19, 2026 | Award | +270,759 | – | – | 517,057 |
| Frederick T. Sullivan Chief Financial Officer | May 19, 2026 | Award | +90,253 | – | – | 231,874 |
| Kenneth L. Horton GC & Corp. Development Advisor | May 19, 2026 | Award | +157,943 | – | – | 295,057 |
| Timothy T. Goodnow President and CEO, Director | May 19, 2026 | Award | +553,701 | – | – | 1,176,346 |
| Frederick T. Sullivan Chief Financial Officer | May 15, 2026 | Tax withholding | −9,005 | $5.82 | $52.41K | 141,621 |
| Kenneth L. Horton GC & Corp. Development Advisor | May 15, 2026 | Tax withholding | −7,320 | $5.82 | $42.60K | 137,114 |
| Mukul JAIN Chief Operating Officer | May 15, 2026 | Tax withholding | −13,681 | $5.82 | $79.62K | 246,298 |
| Timothy T. Goodnow President and CEO, Director | May 15, 2026 | Tax withholding | −28,598 | $5.82 | $166.44K | 622,645 |
| Francine Kaufman Chief Medical Officer, Director | May 15, 2026 | Tax withholding | −6,058 | $5.82 | $35.26K | 117,890 |
| Douglas A. Roeder Director | May 12, 2026 | Buy | +22,686 | $5.56 | $126.13K | 144,635 |
| Edelman Steven Director | Apr 1, 2026 | Award | +1,936 | $6.65 | $12.87K | 78,829 |
| Edward Fiorentino Director | Apr 1, 2026 | Award | +2,124 | $6.65 | $14.12K | 73,487 |
| Douglas A. Roeder Director | Apr 1, 2026 | Award | +2,218 | $6.65 | $14.75K | 121,949 |
| Douglas S. Prince Director | Apr 1, 2026 | Award | +1,221 | $6.65 | $8.12K | 57,964 |
| Timothy T. Goodnow President and CEO, Director | Mar 13, 2026 | Buy | +17,225 | $5.79 | $99.73K | 651,243 |
| Douglas A. Roeder Director | Mar 13, 2026 | Buy | +17,500 | $5.73 | $100.28K | 119,731 |
| Douglas A. Roeder Director | Jan 2, 2026 | Award | +2,504 | $5.89 | $14.75K | 102,231 |
| Douglas S. Prince Director | Jan 2, 2026 | Award | +1,379 | $5.89 | $8.12K | 56,743 |
| Edward Fiorentino Director | Jan 2, 2026 | Award | +2,398 | $5.89 | $14.12K | 71,363 |
| Edelman Steven Director | Jan 2, 2026 | Award | +2,185 | $5.89 | $12.87K | 76,893 |
| Frederick T. Sullivan Chief Financial Officer | Nov 15, 2025 | Tax withholding | −6,402 | $6.26 | $40.08K | 150,626 |
| Timothy T. Goodnow President and CEO, Director | Nov 15, 2025 | Tax withholding | −27,067 | $6.26 | $169.44K | 634,018 |
| Mukul JAIN Chief Operating Officer | Nov 15, 2025 | Tax withholding | −10,317 | $6.26 | $64.58K | 259,979 |
| Kenneth L. Horton GC & Corp. Development Advisor | Nov 15, 2025 | Tax withholding | −5,997 | $6.26 | $37.54K | 144,434 |
| Francine Kaufman Chief Medical Officer, Director | Nov 15, 2025 | Tax withholding | −4,605 | $6.26 | $28.83K | 123,948 |
| Edelman Steven Director | Nov 10, 2025 | Buy | +10,000 | $6.55 | $65.50K | 74,708 |
| Timothy T. Goodnow President and CEO, Director | Nov 7, 2025 | Buy | −17,210 | $5.87 | $101.02K | 661,085 |
| Frederick T. Sullivan Chief Financial Officer | Nov 7, 2025 | Buy | +5,415 | $5.88 | $31.84K | 157,028 |
| Douglas A. Roeder Director | Nov 7, 2025 | Buy | +15,000 | $5.83 | $87.45K | 99,727 |
| Douglas S. Prince Director | Oct 1, 2025 | Award | +19,673 | $0.41 | $8.07K | 1,107,280 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Senseonics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,900 shares on Sep 4, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sharon Larkin Officer | Sep 7, 2023 | 30,889 | $19.15K | Sep 7, 2023 | Restricted Stock Units |
See a number that looks wrong?